| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Robbins Wendye is a Director at RAPT Therapeutics, Inc.. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $261K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2020 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 1,000 | $16.09 | $16,085.00 | +21.7% | |
| Sep 28, 2020 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 500 | $28.70 | $14,350.00 | +4.0% | |
| Sep 24, 2020 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 600 | $28.80 | $17,279.67 | +3.5% | |
| Jul 24, 2020 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 900 | $22.47 | $20,225.00 | +9.4% | |
| Jul 1, 2020 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 2,600 | $26.01 | $67,632.00 | +27.2% | |
| Nov 4, 2019 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 1,600 | $12.00 | $19,200.00 | New |